Research ArticleMuscular Dystrophy

Systemic administration of the antisense oligonucleotide NS-065/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy

See allHide authors and affiliations

Science Translational Medicine  18 Apr 2018:
Vol. 10, Issue 437, eaan0713
DOI: 10.1126/scitranslmed.aan0713

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article